Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2 - Ukey, Rahul; Bruiners, Natalie; Mishra, Hridesh; Mishra, Pankaj K.; McCloskey, Deborah; Onyuka, Alberta; Chen, Fei; Pinter, Abraham; Weiskopf, Daniela; Sette, Alessandro; Roy, Jason; Gaur, Sunanda; et al. (BMC medicine, 2022)
Keywords: Ad26.COV2.S; Ad26COVS1; Analysis; Antibodies; Antibodies, Viral; Antibody binding; Antigen-antibody reactions; Antigen-specific B cells; Antigens; BNT162b2; Cell culture; Correspondence; COVID-19; COVID-19 Vaccines; Durability; FDA approval; Hospital care; Humans; Immunity, Humoral; Immunization; Immunogenicity; Immunology; Infections; Laboratories; Lymphocytes; Lymphocytes T; mRNA; mRNA Vaccines; mRNA-1273; Neutralizing antibodies; Pandemics; Peptides; Plasma; Prevention; Proteins; Public health; Regression analysis; RNA, Messenger - genetics; SARS-CoV-2; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Software; Testing; Vaccination; Vaccines; Viral diseases; Viral infections; United States; United States--US; BNT162b2; Neutralizing antibodies; Ad26.COV2.S; mRNA-1273; Antigen-specific B cells; Antibody binding; Antigen-specific T cells